Industrial and Medical Gases Nigeria PLC

The company maintains a strong liquidity position, with a current ratio of 1.95 and cash and equivalents of NGN 2.24 billion, indicating sufficient short-term assets to cover liabilities. However, its free cash flow is negative at NGN -2.27 billion, primarily due to capital expenditures of NGN -3.24 billion, suggesting significant reinvestment in operations. The debt-to-equity ratio is low at 0.01, reflecting a conservative capital structure with minimal leverage. Profitability metrics show a return on equity of 8.36% and a return on assets of 6.69%, both below the typical thresholds for high-margin chemical producers. The gross profit margin is 49.3% (NGN 4.08 billion on NGN 8.38 billion revenue), but operating income of NGN 1.47 billion and net income of NGN 989.85 million suggest operational efficiency is constrained by high capital outlays. The company serves a broad range of sectors, including healthcare, food and beverage, and industrial processes, with no disclosed revenue concentration above 10% in any single segment. Geographically, it operates primarily in Nigeria, with no material international revenue streams reported. Revenue growth is not explicitly forecasted, but the company’s capital expenditures suggest a focus on long-term infrastructure development. The operating cash flow of NGN 445.47 million indicates some cash generation, though it is insufficient to offset the free cash flow deficit. Risk factors are limited, with no immediate liquidity or dilution concerns identified. The low debt-to-equity ratio and strong cash reserves reduce financial risk, while the absence of dilution sources such as ATM facilities or recent equity offerings supports stability in ownership structure. Recent filings and transcripts do not highlight material events or strategic shifts. The company’s focus remains on core gas production and equipment services, with no disclosed M&A activity or major regulatory changes impacting operations.